国际标准期刊号: 2329-9053

分子药剂学与有机过程研究杂志

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • CAS 来源索引 (CASSI)
  • 哥白尼索引
  • 谷歌学术
  • 夏尔巴·罗密欧
  • 打开 J 门
  • 学术钥匙
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-世界猫
  • 普布隆斯
  • 欧洲酒吧
  • ICMJE
分享此页面

抽象的

Text Mining-Based Drug Discovery in Osteoarthritis

Donghun Trepat

Osteoarthritis is a prevalent degenerative joint disease characterized by the breakdown of articular cartilage and significant pain and functional limitations. Despite its high prevalence and impact on individuals' quality of life, effective therapies for OA are limited. Text mining, a subfield of data mining, offers a powerful approach to leverage the vast amount of biomedical literature and accelerate drug discovery in OA. This journal focuses on the advancements and applications of text mining techniques in OA drug discovery, aiming to uncover novel therapeutic targets, identify drug candidates, and understand disease mechanisms. Through the integration of diverse data sources, including scientific articles, clinical trial reports, and genetic databases, text mining enables the extraction and analysis of valuable information. This approach facilitates the identification of potential targets and pathways implicated in OA pathogenesis, the repurposing of existing drugs for OA treatment, and the development of personalized treatment strategies. However, challenges such as data quality and algorithm performance should be addressed. Experimental validation is crucial to ensure the reliability of text mining-based findings. Text mining-based drug discovery in OA holds great promise for transforming the field and accelerating the development of innovative treatments for this debilitating condition.

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证。